Respivant Sciences

Patient voices are critical in raising awareness of #PFcough & helping prevent misdiagnosis, which happens to ~71% of patients. As we kickoff #PFMonth we are honored to unveil this video chronicling Charlene Marshall's #PF journey. See the full video here: bit.ly/31YU1Tb

Our CEO, @wgerhart, recently spoke with @mdaghbio about the impact the #COVID19 pandemic has had on those with #PF & the ostracization they’ve experienced because of the chronic cough associated with this disease. Read the article in @GlobalGenes here: bit.ly/3iNnIMM

Hear from @IPFWarrior Bill Vick, speak to our CEO @Bill_Gerhart about #PFcough and our #SCENIC trial that is evaluating the potential of #RVT1601 to treat #IPFcough as well as the underlying disease: bit.ly/3fflyTY

It is important to talk to your doctor about your #PFcough as soon as you become concerned or symptoms of excessive coughing occur. The best support from a doctor will come from you being an empowered patient and working with them to identify a treatment option.

The ostracization of cough for those with #PF was significant before #COVID19, but is now significantly worse due to the pandemic, which can lead to increased anxiety, isolation and depression. It's time to stop the stigmatization of #PFcough. Read more in @pulmonaryfibros:

In the time of #COVID19, people are ostracizing those who cough in public, which has created more stress & anxiety for patients who have #PFcough. Charlene Marshall, a #PF patient, shares a few tips in @pulmonaryfibros to help w/ anxiety amid the pandemic: bit.ly/2ZLDtx1

Our CEO, @wgerhart, recently spoke with @dslevine for his #RARECast podcast on @GlobalGenes about #PFcough and our SCENIC study that is evaluating the potential of #RVT1601 to significantly reduce cough & improve quality of life for patients. Listen here:

Dry cough is one of the most common, well-publicized early symptoms of #COVID19. Our CEO @wgerhart shares his thoughts on the stigma behind the cough associated with #PF that has been exacerbated by the #COVID pandemic. Read more here: bit.ly/3jaaWsH #PFcough

The PF Perspectives Project is accepting submissions until June 30 from patients with #PFCough. Your perspective will help healthcare innovators understand pressing challenges for #PF & develop the solutions needed to solve those challenges. bit.ly/3dmZ5mP

Our #SCENIC trial is evaluating the potential of #RVT1601 to treat IPF cough as well as the underlying disease; if successful RVT1601 could be the first therapy approved to significantly improve quality of life for pulmonary fibrosis patients. Learn more: bit.ly/2ASCBgC

#IPF can lead to anxiety, depression and isolation, and many patients shy away from discussing the burden of their #IPFCough. Facilitating conversations around IPF can help others better understand and de-stigmatize this condition. Let’s start the discussion today.

#Pulmonaryfibrosis innovators want to hear from patients with #PFCough. Your perspective can shed light on key problems and opportunity areas for #PF. Share your story with The PF Perspectives Project today:

#IPF is a rare disease which means it’s important to get connected with a #PF specialist to get the best care for your #IPF. Hear more from Taleena Koch, founder of @BreatheWithPF about how to get connected to a #PF specialist near you:

There are currently only 2 approved drugs that have demonstrated the potential to slow the progression of IPF, but neither reduces cough or improves quality of life. We’re evaluating the potential of #RVT1601 to significantly reduce cough & improve quality of life for patients.

There are multiple triggers that can cause patients with #IPF to have an uncontrollable coughing episode, including perfumes, spices, and temperature changes. Potential embarrassment associated with their cough leads many patients with this disease to self-isolate. #IPFStigma

Cough associated with #IPF may be the first symptom a patient experiences, preceding breathlessness by months to years. #FactsAboutIPF #LIVEwithPF #IPFStigma